Company: BIAF
Filing Date: 2025-09-18
Form Type: 424B3
Source: 0001493152-25-014066
Chunk: 22

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-18
Form: 424B3
Chunk 22
---
ETE III” and collectively with EAM and ETE, the “Empery Funds”).                                       
 The shares listed in the second column represent (i) the aforementioned shares, (ii) 797,469 shares of common stock                           
 held by the Empery Funds and (iii) 4,687,500 shares of Common Stock issuable upon exercise of common stock purchase                           
 warrants held by the Empery Funds that were initially issued as registered securities and are not being registered for resale                 
 hereunder. Empery Asset Management LP, the authorized agent of each of the Empery Funds, has discretionary authority to                       
 vote and dispose of the shares held by the Empery Funds and may be deemed to be the beneficial owner of these shares. Martin Hoe              
 and Ryan Lane, in their capacity as investment managers of Empery Asset Management LP, may also be deemed to have investment discretion       
 and voting power over the shares held by the Empery Funds. Each of the Empery Funds, Mr. Hoe and Mr. Lane each disclaim any beneficial        
 ownership of these shares. The business address of Empery Asset Management, LP is 1 Rockefeller Plaza, Suite 1205, New York, New              
 York 10020.                                                                                                                                   |
| (4) | The                                                                                                                                           
 shares listed in the third column consist of (i) 652,173 shares of Common Stock issuable upon conversion of 150 shares of                     
 Series B Preferred Stock, (ii) 1,017,391 shares of Common Stock issuable upon exercise of Private Warrants and (iii) 946,875                  
 shares of Common Stock issuable upon exercise of the May 2025 Warrants. The shares listed in the second column consist of the                 
 (i) aforementioned shares and (ii) 703,125 shares of Common Stock issuable upon exercise of common stock purchase warrants                    
 that were initially issued as registered securities and are not being registered for resale hereunder. Steven Cohen is the                    
 managing member of Alta Partners LLC and has voting control and investment discretion over securities beneficially owned directly             
 by Alta Partners LLC and has voting control and investment discretion over securities beneficially owned directly by Alta Partners            
 LLC. In such role, Mr. Cohen may be deemed to beneficially own the securities owned by Alta Partners LLC. We have been advised that           
 none of Mr. Cohen or Alta Partners LLC is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, 
 an affiliate or associated person of a FINRA member